About US
Contact us
-
CFDA Minister Zhang Yong meets Minister of Food and Drug Safety of the Republic of KoreaOn December 19, 2013, Zhang Yong, Minister of China Food and Drug Administration (CFDA), met with the delegation led by Chung Seung, Minister of Food and Drug Safety of the Republic of Korea. Both sid2013/12/31
-
FDA says nada to Lemtrada; will Sanofi be willing to invest in additional trials?Sanofi ($SNY) intends to appeal the FDA's denial ofLemtrada, itsmultiple sclerosisdrug that was a key reason it paid $20.1 billion to buy Genzyme two years ago. But the question burning in the mind of2013/12/31
-
Aptalis files IPO after owner TPG Capital couldn't find a buyerPrivate investment firms buy up drug companies with the idea of cashing out at some point with a big profit.TPG Capital, unable to find a buyer willing to pay its $3 billion-plus asking price forAptal2013/12/30
-
German Merck is among the companies fishing in Iran for more businessPharmaceuticals are among the small number of products that Western companies can still sell to Iran under the sanctions program designed to deter its nuclear ambitions. The process, however, is compl2013/12/30
-
GSK obtains European approval for Cervarix two-dose scheduleGlaxoSmithKline (GSK) has received marketing authorisation from the European Commission for its cervical cancer vaccine Cervarix as a two-dose schedule for girls aged nine to 14 years. Cervarix [Huma2013/12/27
-
Roche's rheumatoid arthritis drug RoACTEMRA gets CHMP positive opinionRoche has received positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for its subcutaneous formulation of RoACTEMRA (tocilizumab) to treat mode2013/12/27
-
PHEXCOM has sponsored and joined in the celebration for the elderly people in GuangQi Nursing House together with over 80 volunteers on 21th Dec, 2013Currently around 100 elderly people lived in Guangqi Nursing House and they are aged from 70 years old to 101 years old. Basically 3-4 people are living in one room. Most of them have religions of Cat2013/12/26
-
ATMI Announces Agreement to Sell LifeScienc​es Business to Pall Corporatio​nATMI, Inc., a global technology company and leader in single-use bioprocess solutions, has reached agreement with Pall Corporation to sell ATMI LifeSciences in a transaction valued at $185 million.2013/12/26
-
Novo gets a year-end win for Factor XIII blood-clotting product after two rejectionsThree's a charm for Novo Nordisk ($NVO) and its recombinant Factor XIII compound for a rare bleeding disorder. After receiving a complete response letter (CRL) in 2012 and then again this August, the2013/12/26
-
FDA approves Baxter's FEIBA for prophylactic treatment of hemophilia A&B patients with inhibitorsThe US Food and Drug Administration (FDA) has approved Baxter's FEIBA [anti-inhibitor coagulant complex] for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in hemophilia A2013/12/25